Montreal is home to some of the most respected medical research institutions in Canada, yet thousands of Montrealers living with persistent hypothyroid symptoms struggle to access the thyroid therapies they need. If you are in Montreal and dealing with fatigue, brain fog, weight gain, or cold intolerance despite being on levothyroxine, you are not alone. The gap between what the research literature supports and what the Quebec healthcare system routinely offers remains substantial -- particularly when it comes to T3 therapy.
Slow release T3 (sustained-release liothyronine) is designed to deliver the active thyroid hormone your body needs in a steady, controlled manner that mimics natural thyroid secretion. Unlike instant-release Cytomel, which produces sharp spikes and rapid crashes in serum T3 levels, a sustained-release formulation maintains stable hormone levels over eight to twelve hours. For Montreal residents who have tried levothyroxine alone without adequate relief, slow release T3 represents a meaningful option worth investigating.
Why Slow Release T3 Matters for Montreal Researchers
Montreal's research community has long been at the forefront of endocrine science. McGill University's Department of Medicine and the Universite de Montreal's Faculty of Medicine have both contributed to the body of literature on thyroid hormone metabolism, peripheral conversion, and the limitations of T4-only replacement therapy. The research coming out of these institutions supports what many patients already know from lived experience: levothyroxine monotherapy does not resolve symptoms for everyone.
Quebec's public healthcare system, administered through the RAMQ, covers standard thyroid medications including levothyroxine and, in some cases, immediate-release liothyronine (Cytomel). However, compounded slow-release T3 formulations fall outside the standard RAMQ drug formulary. This means that even when a Quebec physician is willing to prescribe compounded sustained-release liothyronine, patients typically pay entirely out of pocket. Costs at Montreal compounding pharmacies range from $90 to $160 per month, and wait times for custom preparations can stretch to a week or longer.
The challenge is compounded by Quebec's physician culture around thyroid management. Many family doctors and endocrinologists in the province follow the Canadian Thyroid Association guidelines closely, which still emphasize TSH as the primary metric and levothyroxine as the default therapy. Patients whose TSH falls within the reference range but whose Free T3 sits in the lower third -- or whose Reverse T3 is disproportionately elevated -- often find their concerns dismissed. If your doctor has told you that your levels are "normal" while your symptoms persist, the frustration is understandable. Our article on why levothyroxine is not working and when to consider adding T3 addresses this clinical disconnect in detail.
For those interested in the Wilson's Temperature Syndrome protocol, which uses sustained-release T3 to address low basal body temperature and metabolic dysfunction, Montreal's climate makes temperature monitoring particularly relevant. Cold winters can mask the chronic cold intolerance that many hypothyroid patients experience, making basal body temperature tracking an essential objective measure. The Wilson's T3 Protocol guide explains how this approach uses slow release T3 in timed cycles to reset thyroid function.
Thyroid dysfunction does not exist in isolation. For women in Montreal navigating perimenopause or menopause alongside hypothyroid symptoms, the hormonal interplay can intensify fatigue, mood disturbances, and metabolic slowdown. Our guide on thyroid and menopause explores how declining oestrogen and progesterone interact with thyroid hormone metabolism and why T3 support becomes particularly relevant during this transition.
How to Get SRT3 Shipped to Montreal
Ordering research-grade slow release T3 with delivery to Montreal is straightforward. All orders ship domestically within Canada via Canada Post, which means your package never crosses an international border and never passes through customs. This eliminates the seizure risks and delays associated with importing thyroid compounds from overseas suppliers.
For Montreal addresses, typical delivery times are three to five business days from shipment. Canada Post's service within Quebec is generally reliable, and Montreal's position as a major postal hub means packages move through sorting facilities efficiently. All shipments are sent in discreet, unmarked packaging with no indication of the contents on the exterior.
Because this is a domestic Canadian shipment, there are no brokerage fees, no customs declarations, and no import duties. The package arrives at your door -- or your local post office if you prefer a FlexDelivery address -- just like any other Canada Post parcel. Tracking information is provided with every order so you can monitor delivery progress.
Montreal residents in all boroughs and surrounding areas are served, including downtown, the Plateau, NDG, Verdun, Hochelaga-Maisonneuve, Laval, Longueuil, and the broader Greater Montreal Area. Whether you are near the McGill campus or out in the West Island, delivery timelines remain consistent within the three to five business day window.
Available SRT3 Dosages
Research-grade slow release T3 is available in four standardized dosage strengths. Each is manufactured using a consistent sustained-release matrix, ensuring identical release kinetics from batch to batch -- something compounding pharmacies cannot reliably guarantee.
-
SRT3-7.5 -- 7.5mcg per capsule. The ideal starting point for those new to T3 therapy or anyone who prefers a conservative titration approach. This low dose allows you to assess your response with minimal risk of overstimulation. Many practitioners recommend beginning here and increasing gradually based on symptom response and lab results.
-
SRT3-15 -- 15mcg per capsule. The most commonly used strength for combination T4/T3 therapy. A 15mcg slow release capsule taken once or twice daily provides a physiological level of T3 supplementation that complements standard levothyroxine dosing. This is the strength most Montreal customers start with or move to after initial titration.
-
SRT3-22.5 -- 22.5mcg per capsule. A mid-range option for individuals who have established that they need more than 15mcg but do not require a full 45mcg dose. This strength reduces the number of capsules needed per day while maintaining precise dosing.
-
SRT3-45 -- 45mcg per capsule. Designed for those on established higher-dose protocols, including Wilson's T3 Protocol cycles that call for elevated T3 doses during the ramping phase. This strength is typically used by experienced individuals who have already titrated through lower doses under appropriate monitoring.
All four strengths can be combined to achieve custom total daily doses. For example, one SRT3-7.5 capsule plus one SRT3-15 capsule yields a 22.5mcg total dose, giving you the same flexibility as a compounding pharmacy without the batch variability.
Frequently Asked Questions
Can I get slow release T3 delivered to Montreal without a prescription?
Yes. Research-grade slow release T3 does not require a prescription for purchase in Canada. You can order directly online and have it shipped to any Montreal address via Canada Post. This removes the barrier of finding a willing prescriber in Quebec's healthcare system, which remains one of the most significant obstacles for Montrealers seeking T3 therapy through conventional channels.
How long does shipping take to Montreal?
Orders ship domestically within Canada via Canada Post. Delivery to Montreal addresses typically takes three to five business days from the date of shipment. As a major urban centre and postal hub, Montreal generally receives packages on the faster end of that range. Tracking is provided with every order.
Is slow release T3 the same as Cytomel?
Both slow release T3 and Cytomel contain the same active molecule -- liothyronine sodium (T3). The critical difference is the delivery method. Cytomel is an immediate-release tablet that dumps its full dose into your bloodstream within two to four hours, creating a sharp peak followed by a rapid decline. Slow release T3 uses a sustained-release matrix to deliver the hormone gradually over eight to twelve hours, producing stable serum levels without the spike-and-crash pattern. This distinction matters clinically because steady T3 levels more closely mimic how a healthy thyroid gland naturally secretes the hormone.
What dose of slow release T3 should I start with?
If you are new to T3 therapy, starting with the lowest available dose (7.5mcg) is the most conservative and widely recommended approach. This allows you to evaluate your response -- improvements in energy, body temperature, cognitive clarity -- without risking overstimulation. After two to four weeks at 7.5mcg, you can assess whether to increase. Many people find their optimal dose falls between 15mcg and 30mcg per day, taken as one or two capsules depending on the strength selected.
Can I use slow release T3 alongside my current levothyroxine prescription?
Absolutely. Combination T4/T3 therapy is the most common use case for slow release T3. Most people continue taking their existing levothyroxine dose and add slow release T3 to address the gap left by insufficient T4-to-T3 conversion. Some practitioners recommend a modest reduction in the T4 dose when introducing T3, while others maintain the existing T4 dose and allow lab results to guide adjustments over time. Regular monitoring of Free T3, Free T4, and TSH is important when running combination therapy to ensure you remain within therapeutic range.